Bigora Sian 4/A

What Happened

• Bigora Sian, Chief Development Officer of Processa Pharmaceuticals (PCSA), reported an open-market/private purchase of 1,971 shares on 2026-04-30 at $2.71 per share, for a total of $5,341. The Form 4 was filed as an amended report.

Key Details

• Transaction date and price: 2026-04-30, purchase at $2.71 per share.
• Total purchased: 1,971 shares; total value: $5,341.
• Filing: Amended Form 4 filed 2026-05-19 (the amendment notes adjusted share figures for immaterial errors).
• Footnote: F1 indicates shares were adjusted to correct immaterial errors.
• Shares owned after the transaction: Not disclosed in the provided filing excerpt.
• Transaction code: P = Purchase (open market or private purchase).

Context

• Purchases (P) are a direct buy of company stock and can be more informative than sales, but this is a small-dollar purchase and should be interpreted cautiously.
• The filing was amended to correct immaterial errors; no derivative exercises, gift, or tax-withholding actions were reported.